Results for: drugmaker

India's Ranbaxy quarterly loss rises

Drugmaker AbbVie beats estimates as Humira sales rise

EU clears plans by drugmakers GSK and Novartis to trade assets

Pfizer's 2015 forecast disappoints, crimped by generics, dollar

Novo Nordisk Fourth-Quarter Net Beats Estimates on Victoza

Pfizer $33 Billion Question Remains After Teva, Actavis Feelers

Pfizer beats Street 4Q forecasts

Sun Pharmaceutical wins U.S. approval to buy Ranbaxy

Novartis Sees Sales Gain Resuming After Earnings Beat Estimates

AbbVie reports better-than-expected 4Q on Humira sales

EU puts conditions on deals involving Novartis, GSK

Pfizer earnings slip on loss of drug patent exclusivity